SCN4B inhibits the progression of lung adenocarcinoma and is associated with better prognosis

ConclusionSCN4B expresses higher in normal samples, and SCN4B is able to be an independent prognostic signature for LUAD patients. TAL1 and ERG may regulate the expression of SCN4B by binding its upstream sequences. Our research is valuable in improving the effectiveness of treatment in LUAD.

Source: The Clinical Respiratory Journal - October 12, 2023 Category: Respiratory Medicine Authors: Minting Ma, Bin Guo, Hongwei Lu, Lei Hong Tags: ORIGINAL ARTICLE Source Type: research